Next Article in Journal
Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis
Next Article in Special Issue
Boosted Pro-Inflammatory Activity in Human PBMCs by Lipopolysaccharide and SARS-CoV-2 Spike Protein Is Regulated by α-1 Antitrypsin
Previous Article in Journal
CX-5461 Enhances the Efficacy of APR-246 via Induction of DNA Damage and Replication Stress in Triple-Negative Breast Cancer
Previous Article in Special Issue
The Importance of N186 in the Alpha-1-Antitrypsin Shutter Region Is Revealed by the Novel Bologna Deficiency Variant
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Hepatic and Extrahepatic Sources and Manifestations in Endoplasmic Reticulum Storage Diseases

by
Francesco Callea
1,*,
Paola Francalanci
2,* and
Isabella Giovannoni
2
1
Bugando Medical Centre, Department of Molecular Histopathology, Catholic University Health Allied Sciences, Mwanza P.O. Box 1464, Tanzania
2
Department of Pathology, Childrens’ Hospital Bambino Gesù IRCCS, 00165 Rome, Italy
*
Authors to whom correspondence should be addressed.
Int. J. Mol. Sci. 2021, 22(11), 5778; https://doi.org/10.3390/ijms22115778
Submission received: 6 May 2021 / Revised: 21 May 2021 / Accepted: 23 May 2021 / Published: 28 May 2021

Abstract

Alpha-1-antitrypsin (AAT) and fibrinogen are secretory acute phase reactant proteins. Circulating AAT and fibrinogen are synthesized exclusively in the liver. Mutations in the encoding genes result in conformational abnormalities of the two molecules that aggregate within the rough endoplasmic reticulum (RER) instead of being regularly exported. That results in AAT-deficiency (AATD) and in hereditary hypofibrinogenemia with hepatic storage (HHHS). The association of plasma deficiency and liver storage identifies a new group of pathologies: endoplasmic reticulum storage disease (ERSD).
Keywords: alpha-1-antitrypsin; fibrinogen; hepatic; extrahepatic; deficiency; manifestation alpha-1-antitrypsin; fibrinogen; hepatic; extrahepatic; deficiency; manifestation

Share and Cite

MDPI and ACS Style

Callea, F.; Francalanci, P.; Giovannoni, I. Hepatic and Extrahepatic Sources and Manifestations in Endoplasmic Reticulum Storage Diseases. Int. J. Mol. Sci. 2021, 22, 5778. https://doi.org/10.3390/ijms22115778

AMA Style

Callea F, Francalanci P, Giovannoni I. Hepatic and Extrahepatic Sources and Manifestations in Endoplasmic Reticulum Storage Diseases. International Journal of Molecular Sciences. 2021; 22(11):5778. https://doi.org/10.3390/ijms22115778

Chicago/Turabian Style

Callea, Francesco, Paola Francalanci, and Isabella Giovannoni. 2021. "Hepatic and Extrahepatic Sources and Manifestations in Endoplasmic Reticulum Storage Diseases" International Journal of Molecular Sciences 22, no. 11: 5778. https://doi.org/10.3390/ijms22115778

APA Style

Callea, F., Francalanci, P., & Giovannoni, I. (2021). Hepatic and Extrahepatic Sources and Manifestations in Endoplasmic Reticulum Storage Diseases. International Journal of Molecular Sciences, 22(11), 5778. https://doi.org/10.3390/ijms22115778

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop